Black Diamond Therapeutics (BDTX)
(Delayed Data from NSDQ)
$6.11 USD
-0.64 (-9.48%)
Updated May 10, 2024 04:00 PM ET
After-Market: $6.12 +0.01 (0.16%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/09/2024
Time: -- |
6/2024 | $-0.41 | -2.44% |
Earnings Summary
For their last quarter, Black Diamond Therapeutics (BDTX) reported earnings of -$0.35 per share, beating the Zacks Consensus Estimate of $-0.44 per share. This reflects a positive earnings surprise of 20.45%. Look out for BDTX's next earnings release expected on August 09, 2024. For the next earning release, we expect the company to report earnings of -$0.41 per share, reflecting a year-over-year increase of 21.15%.
Earnings History
Price & Consensus
Zacks News for BDTX
Black Diamond (BDTX) is on the Move, Here's Why the Trend Could be Sustainable
BDTX: What are Zacks experts saying now?
Zacks Private Portfolio Services